Tom Fitton @TomFitton
The Centers for Medicare and Medicaid Services refused to cover a novel Alzheimer’s treatment for millions of patients because it disagreed with the FDA’s approval. #Obamacare. https://t.co/kkaAR7GZFO via @WSJOpinion — PolitiTweet.org